Infinium Pharmachem Limited (NSE:INFINIUM)

Market Cap	4.01B
Revenue (ttm)	1.57B
Net Income (ttm)	94.99M
Shares Out	13.92M
EPS (ttm)	6.83
PE Ratio	42.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,500
Average Volume	7,275
Open	335.50
Previous Close	325.35
Day's Range	315.05 - 335.50
52-Week Range	178.05 - 392.50
Beta	0.52
RSI	45.90
Earnings Date	May 16, 2025

About Infinium Pharmachem

Infinium Pharmachem Limited engages in the manufacture and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs) in India and internationally. The company provides iodine derivatives and iodine based molecules / APIs / Iodination reaction based bulk drugs. It also provides potassium iodide and iodate, sodium iodide, iodine, povidone, and iodoform products. In addition, the company offers integrated contract research and manufacturing services to pharmaceutical, agrochemical, nutraceutical, specialty chemicals and ot...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2003
• Employees: 118
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INFINIUM

Financial Performance

In 2023, Infinium Pharmachem's revenue was 1.36 billion, an increase of 18.75% compared to the previous year's 1.14 billion. Earnings were 113.02 million, an increase of 19.10%.